Position in HLN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$317
-$18,151 QoQ
Shares Held
34
-98.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#625
of 639 holders
Holding Since
Sep 2023
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Operose Advisors LLC holds $123,376 across 3 Drug Manufacturers - Specialty & Generic names. HLN ranks #3 (0.3% of the industry book) .
All Filings in HLN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $317 | 34 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $18,468 | 1,845 | Shares | Sole | 2026-05-12 | |
| 2024-09-30 | $11,595 | 1,096 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $9,052 | 1,096 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $9,305 | 1,096 | Shares | Sole | 2024-05-13 | |
| 2023-09-30 | $9,129 | 1,096 | Shares | Sole | 2023-11-13 | |
| No filing history on record for this holder in this stock. | ||||||